NDC 53329-601-28 - Medline
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53329-601
- Requested NDC
- 53329-601-28
- Package NDCs from labels
- 53329-601-28, 53329-601-09
- Manufacturer
- Medline Industries, LP
- Effective date
- 2026-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Medline - Medline Industries, LP | Medline Industries, LP | 2026-08-28 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin | ASPIRIN | Rugby Laboratories | f7ca9f4a-f8ef-46d2-9536-b69541e6653d | 2026-07-02 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | United Natural Foods, Inc. dba UNFI | 19c7f832-d7ec-4dcc-8aa4-f4cbf64c9ff6 | 2026-07-02 | Warnings | R16CO5Y76E |
| Aspirin 325 mg | ASPIRIN | Hi-Tech Nutraceuticals, LLC | b3426a9a-ea99-da30-e053-2995a90a1e4b | 2026-07-01 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Salado Sales, Inc. | ca21d576-be3c-495d-9dbd-ed514bf65da7 | 2026-07-01 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Wal-Mart Stores Inc | 9b1201af-c802-4e19-b192-bbbf34367db4 | 2026-06-30 | Warnings | R16CO5Y76E |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | United Natural Foods, Inc. dba UNFI | b6ff2b34-51ee-41bc-8b7d-7520ade0bf36 | 2026-06-30 | Warnings | R16CO5Y76E |
| Medline | ASPIRIN | Medline Industries, LP | 4b0c569a-ed7a-e104-e063-6394a90a6d54 | 2026-06-29 | Warnings | R16CO5Y76E |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eab581-bc48-f9f0-e063-6394a90a4b93 | 2026-06-25 | IY9XDZ35W2 | |
| Aspirin | ASPIRIN | Strategic Sourcing Services LLC | ea2ef485-429e-4c63-ba7b-0a6b32892ad2 | 2026-06-25 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Chain Drug Marketing Association, Inc. | 055d8420-c189-4a9e-acdc-21627935c8eb | 2026-06-25 | Warnings | R16CO5Y76E |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Topco Associates, LLC | 5f32cf74-dbea-496c-ba23-2040ea354f40 | 2026-06-25 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Salado Sales, Inc. | cf3139a5-e36e-48e3-bb6c-e102b0cec555 | 2026-06-25 | Warnings | R16CO5Y76E |
| Pain Relief Aspirin | ASPIRIN | Rite Aid Corporation | bd69d3d2-5d38-47c6-98a6-124f7a43b8b0 | 2026-06-25 | Warnings | R16CO5Y76E |
| Aspirin Regular Strength | ASPIRIN | Walgreen Company | 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | 2026-06-25 | Warnings | R16CO5Y76E |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54fdf3cf-41df-af7d-e063-6294a90ab1e6 | 2026-06-24 | IY9XDZ35W2 | |
| Aspirin Low Dose | ASPIRIN | ARMY AND AIR FORCE EXCHANGE SERVICE | e273ead7-7cbc-4fd5-a136-9d3558a35360 | 2026-06-24 | Warnings | R16CO5Y76E |
| Blood Collection System | CP2D/AS-3 TRIPLE WITH SAMPLING SYSTEM | GVS TM INC | 54e8cfd2-f91b-8381-e063-6394a90a3f77 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54e9a497-7a94-44c9-e063-6294a90a84da | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb0462-cd00-4467-e063-6394a90aa371 | 2026-06-23 | IY9XDZ35W2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.